Suppr超能文献

CRISPR-Cas9技术在基因组编辑中的生物伦理问题。

Bioethical issues in genome editing by CRISPR-Cas9 technology.

作者信息

Ayanoğlu Fatma Betül, Elçin Ayşe Eser, Elçin Yaşar Murat

机构信息

Tissue Engineering, Biomaterials and Nanobiotechnology Laboratory, Ankara University Faculty of Science,Ankara University Biotechnology Institute, Ankara University Stem Cell Institute, Ankara Turkey.

Biovalda Health Technologies, Inc., Ankara Turkey.

出版信息

Turk J Biol. 2020 Apr 2;44(2):110-120. doi: 10.3906/biy-1912-52. eCollection 2020.

Abstract

Genome editing technologies have led to fundamental changes in genetic science. Among them, CRISPR-Cas9 technology particularly stands out due to its advantages such as easy handling, high accuracy, and low cost. It has made a quick introduction in fields related to humans, animals, and the environment, while raising difficult questions, applications, concerns, and bioethical issues to be discussed. Most concerns stem from the use of CRISPR-Cas9 to genetically alter human germline cells and embryos (called germline genome editing). Germline genome editing leads to serial bioethical issues, such as the occurrence of undesirable changes in the genome, from whom and how informed consent is obtained, and the breeding of the human species (eugenics). However, the bioethical issues that CRISPR-Cas9 technology could cause in the environment, agriculture and livestock should also not be forgotten. In order for CRISPR-Cas9 to be used safely in all areas and to solve potential issues, worldwide legislation should be prepared, taking into account the opinions of both life and social scientists, policy makers, and all other stakeholders of the sectors, and CRISPR-Cas9 applications should be implemented according to such legislations. However, these controls should not restrict scientific freedom. Here, various applications of CRISPR-Cas9 technology, especially in medicine and agriculture, are described and ethical issues related to genome editing using CRISPR-Cas9 technology are discussed. The social and bioethical concerns in relation to human beings, other organisms, and the environment are addressed.

摘要

基因组编辑技术给遗传科学带来了根本性变革。其中,CRISPR - Cas9技术因其操作简便、准确性高和成本低等优势而格外突出。它已在与人类、动物和环境相关的领域迅速得到应用,同时也引发了一些有待探讨的难题、应用、担忧及生物伦理问题。大多数担忧源于使用CRISPR - Cas9对人类生殖系细胞和胚胎进行基因改造(即生殖系基因组编辑)。生殖系基因组编辑引发了一系列生物伦理问题,比如基因组中出现不良变化、如何以及从何人处获得知情同意,以及人类物种的繁育(优生学)。然而,也不应忘记CRISPR - Cas9技术在环境、农业和畜牧业中可能引发的生物伦理问题。为了使CRISPR - Cas9能在所有领域安全使用并解决潜在问题,应在考虑生命科学家、社会科学家、政策制定者以及该领域所有其他利益相关者意见的基础上,制定全球范围的立法,并依据此类立法实施CRISPR - Cas9的应用。然而,这些管控不应限制科学自由。在此,将描述CRISPR - Cas9技术的各种应用,尤其是在医学和农业领域的应用,并讨论与使用CRISPR - Cas9技术进行基因组编辑相关的伦理问题。文中还将探讨与人类、其他生物及环境相关的社会和生物伦理担忧。

相似文献

1
Bioethical issues in genome editing by CRISPR-Cas9 technology.
Turk J Biol. 2020 Apr 2;44(2):110-120. doi: 10.3906/biy-1912-52. eCollection 2020.
3
Islamic Perspectives on CRISPR/Cas9-Mediated Human Germline Gene Editing: A Preliminary Discussion.
Sci Eng Ethics. 2020 Feb;26(1):309-323. doi: 10.1007/s11948-019-00098-z. Epub 2019 Mar 4.
4
CRISPR-Cas9 system: A genome-editing tool with endless possibilities.
J Biotechnol. 2020 Aug 10;319:36-53. doi: 10.1016/j.jbiotec.2020.05.008. Epub 2020 May 22.
5
-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool.
Cell Biosci. 2020 Mar 30;10:48. doi: 10.1186/s13578-020-00410-6. eCollection 2020.
7
Human Genome Editing and Ethical Considerations.
Sci Eng Ethics. 2016 Apr;22(2):597-9. doi: 10.1007/s11948-015-9675-8. Epub 2015 Jul 8.
8
The Impact of CRISPR/Cas9 Technology on Cardiac Research: From Disease Modelling to Therapeutic Approaches.
Stem Cells Int. 2017;2017:8960236. doi: 10.1155/2017/8960236. Epub 2017 Dec 25.
9
CRISPR-Cas9: Tool for Qualitative and Quantitative Plant Genome Editing.
Front Plant Sci. 2016 Nov 21;7:1740. doi: 10.3389/fpls.2016.01740. eCollection 2016.
10
The Wisdom of Germline Editing: An Ethical Analysis of the Use of CRISPR-Cas9 to Edit Human Embryos.
New Bioeth. 2019 Jun;25(2):137-152. doi: 10.1080/20502877.2019.1606151.

引用本文的文献

2
CRISPR/Cas9 and iPSC-Based Therapeutic Approaches in Alzheimer's Disease.
Antioxidants (Basel). 2025 Jun 25;14(7):781. doi: 10.3390/antiox14070781.
3
Beyond human limits: the ethical, social, and regulatory implications of human enhancement.
Front Med (Lausanne). 2025 Jul 9;12:1595213. doi: 10.3389/fmed.2025.1595213. eCollection 2025.
4
CRISPR-Cas9 in the Tailoring of Genetically Engineered Animals.
Curr Issues Mol Biol. 2025 May 4;47(5):330. doi: 10.3390/cimb47050330.
5
Beyond the lab: future-proofing agriculture for climate resilience and stress management.
Front Plant Sci. 2025 Jun 13;16:1565850. doi: 10.3389/fpls.2025.1565850. eCollection 2025.
6
A review on the mechanism and potential diagnostic application of CRISPR/Cas13a system.
Mamm Genome. 2025 Jun 24. doi: 10.1007/s00335-025-10143-x.
7
Gene editing therapy as a therapeutic approach for cardiovascular diseases in animal models: A scoping review.
PLoS One. 2025 Jun 4;20(6):e0325330. doi: 10.1371/journal.pone.0325330. eCollection 2025.
8
CRISPR/Cas9: efficient and emerging scope for Brassica crop improvement.
Planta. 2025 Jun 4;262(1):14. doi: 10.1007/s00425-025-04727-9.
9
The CRISPR-Cas revolution in head and neck cancer: a new era of targeted therapy.
Funct Integr Genomics. 2025 May 30;25(1):113. doi: 10.1007/s10142-025-01612-2.
10
Innovative approaches for the treatment of stroke: a recent update.
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 29. doi: 10.1007/s00210-025-04288-4.

本文引用的文献

1
Societal and Ethical Impacts of Germline Genome Editing: How Can We Secure Human Rights?
CRISPR J. 2019 Oct;2(5):293-298. doi: 10.1089/crispr.2019.0042.
2
The Daunting Economics of Therapeutic Genome Editing.
CRISPR J. 2019 Oct;2(5):280-284. doi: 10.1089/crispr.2019.0052.
3
Human Germline Genome Editing: An Assessment.
CRISPR J. 2019 Oct;2(5):253-265. doi: 10.1089/crispr.2019.0038.
4
Heritable Genome Editing and the Downsides of a Global Moratorium.
CRISPR J. 2019 Oct;2(5):272-279. doi: 10.1089/crispr.2019.0016.
5
Heritable Genome Editing: Who Speaks for "Future" Children?
CRISPR J. 2019 Oct;2(5):285-292. doi: 10.1089/crispr.2019.0019.
6
Human-Animal Chimeras: The Moral Insignificance of Uniquely Human Capacities.
Hastings Cent Rep. 2019 Sep;49(5):23-32. doi: 10.1002/hast.1051.
7
Human-Animal Chimeras, "Human" Cognitive Capacities, and Moral Status.
Hastings Cent Rep. 2019 Sep;49(5):33-34. doi: 10.1002/hast.1052.
8
Ethics assessment in research proposals adopting CRISPR technology.
Biochem Med (Zagreb). 2019 Jun 15;29(2):020202. doi: 10.11613/BM.2019.020202.
9
Do CRISPR Germline Ethics Statements Cut It?
CRISPR J. 2018 Apr;1(2):115-125. doi: 10.1089/crispr.2017.0024.
10
Genome Editing B.C. (Before CRISPR): Lasting Lessons from the "Old Testament".
CRISPR J. 2018 Feb;1(1):34-46. doi: 10.1089/crispr.2018.29007.fyu.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验